RE:RE:RE:RE:RE:RE:RE:Dumped 2/3rds of my shares in the mid $2.70sIt is too bad management (aka PG) has not been more open with investors. Lots of mistrust as a result. The story has always sounded good and hence the optimism over the past numerous months. Hopefully we are not getting played again. We just don't know at this point in time. I am glad I have been able to recoup approx $35K of my prior KNR losses by crystallizing gains over the past few weeks. If we ever do get meaningful BioCloud sales numbers that reflect what most here belief is the potential, we will see the sharp upward share price movement we have all been hoping for. When I start seeing real inspiring results I will jump on and add back to my position with a big order and ride the uplift.This eliminates some of the risk and the gains can still be pretty nice.
canyousayiii wrote: You have been pretty clear that your trust in KNR is not where it should be to buy and hold. Neither is mine, but I am counting on them learning a lot from terrible misjudgment that cost a lot of investors so that they are not throwing all these things at us while not expecting much from them. That is to say, I am expecting many thousands of units sold through Steelcase, otherwise Paul would yet again be throwing big numbers at us that reasonable folk would easily misinterpret. He better not be throwing a network of 800 distributors in our face where on average each one would not be able to sell even 1 piddly unit per month. That's what I am banking on, not shocking the investor community again. We shall see.